Can used insulin glargine (Lantus) be stored at room temperature?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Used glargine insulin can be stored at room temperature (59-86°F or 15-30°C) for up to 28 days after first use, as recommended by recent guidelines 1. When storing used glargine insulin at room temperature, it's essential to protect it from direct heat and light, and never freeze insulin. Unused insulin glargine should be stored in the refrigerator (36-46°F or 2-8°C) until its expiration date. The benefits of room temperature storage include less painful injections, as cold insulin can be more painful to inject. However, the 28-day limit exists because insulin gradually loses potency after opening due to degradation from exposure to air and repeated needle insertions, which can introduce contaminants. Always check the insulin for any changes in appearance (cloudiness, particles, or discoloration) before use, and discard it after 28 days even if there's solution remaining, as suggested by recent expert recommendations 1. Key considerations for insulin storage and handling include:

  • Storing unopened insulin vials/pens in a refrigerator at 2 to 8 °C (36 to 46 °F)
  • Storing opened insulin vials/pens at ambient temperatures (15 to 30 °C or 59 to 86 °F) away from direct sunlight exposure
  • Avoiding removal of insulin from a prefilled disposable insulin pen using a syringe to fill another device unless absolutely necessary
  • Checking the temperature of the refrigerator where insulin is stored to ensure it's within the recommended range.

From the FDA Drug Label

After Insulin Glargine vials have been opened (in-use) Store in-use (opened) Insulin Glargine vials in a refrigerator from 36°F to 46°F (2°C to 8°C) or at room temperature below 86°F (30°C) for up to 28 days.

Used glargine vials can be stored at room temperature below 86°F (30°C) for up to 28 days after opening. However, it is essential to follow the storage instructions carefully to maintain the efficacy and safety of the insulin. 2

From the Research

Storage of Used Glargine

  • The storage of used glargine at room temperature is not directly addressed in the provided studies 3, 4, 5, 6, 7.
  • However, study 3 mentions that insulin glargine has a 28-day limit on the use of a 10-mL (1000 units) multiple-dose vial once the bottle is punctured, but it does not specify the storage conditions for used glargine.
  • Study 4 discusses the allowable room temperature excursions for refrigerated medications, but it does not provide specific information on the storage of used glargine at room temperature.
  • Studies 5, 6, 7 focus on the pharmacology, efficacy, and safety of insulin glargine, but they do not address the storage of used glargine at room temperature.

Stability and Sterility of Used Glargine

  • Study 3 notes that using insulin glargine beyond the 28-day window can result in questionable stability and sterility of the product.
  • However, it does not provide information on the storage conditions that can affect the stability and sterility of used glargine.
  • There is no direct evidence in the provided studies to support or refute the storage of used glargine at room temperature 3, 4, 5, 6, 7.

Related Questions

For a patient taking 24 units of insulin glargine (Lantus) daily, how many bottles (vials) are needed?
For a 45‑year‑old Hispanic male with newly diagnosed diabetes (A1C 14.5 %), creatinine 0.68 mg/dL, eGFR >90 mL/min/1.73 m², weight 98.4 kg, not in diabetic ketoacidosis, and recent insulin drip rates of 2, 2, 3, 2, 2, 3 units over the past 6 hours, what should his once‑daily basal insulin (insulin glargine, Lantus) dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be?
What should be the dose of insulin glargine (Lantus), insulin sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) for a 45‑year‑old man weighing 98.4 kg with newly diagnosed type 2 diabetes, hemoglobin A1c 14.5%, normal renal function, not in diabetic ketoacidosis, who received insulin drip rates of 2, 2, 3, 2, 2, 3, 3, 3, and 2 units over the past 8 hours?
A 46-year-old woman with a current hemoglobin A1c of 6.2% (previously 11.6% nine months ago) has fasting glucose around 150 mg/dL; should she continue taking 15 units of insulin glargine (Lantus) at bedtime and 7 units of insulin lispro with each meal?
For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
What diagnostic tests can be used to determine the type of kidney stone (nephrolithiasis) a patient has?
Is Clobetasol (clobetasol propionate) effective for treating androgenic alopecia?
What laboratory tests distinguish Acute Kidney Injury (AKI) from Chronic Kidney Disease (CKD)?
What is the role of albumin in acute pancreatitis?
Is Spring Valley Omega-3 (Fish Oil) recommended for hypertriglyceridemia?
What over-the-counter (OTC) omega-3 fatty acid supplement is recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.